(AMBQ) Ambiq Micro - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0231931058
Stock:
Total Rating 38
Risk 36
Buy Signal 0.93
| Risk 5d forecast | |
|---|---|
| Volatility | 58.1% |
| Relative Tail Risk | -0.90% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.91 |
| Alpha | 19.94 |
| Character TTM | |
|---|---|
| Beta | 0.888 |
| Beta Downside | 1.228 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.10% |
| CAGR/Max DD | 1.46 |
EPS (Earnings per Share)
Revenue
Description: AMBQ Ambiq Micro
Ambiq Micro, Inc. develops ultra-low-power semiconductor solutions in the United States, Europe, Asia, and internationally. It develops subthreshold power-optimized technology based on ultra-low-power real-time clock and microcontroller products for application in wearables, smart cards, wireless sensors, and Internet-of-Things (IoT) products. The company's flagship products include Apollo, a system on a chip for edge AI devices with host processors capable of software-based AI computations; and Atomiq, targeting AI applications to provide AI acceleration along with new memory innovations. The company also offers technical support services. The company offers its products through internal direct sales force and through a network of distributors and sales representatives. Ambiq Micro, Inc. was formerly known as Cubiq Microchip, Inc. and changed its name to Ambiq Micro, Inc. in October 2012. The company was incorporated in 2010 and is based in Austin, Texas.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -36.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.11 > 0.02 and ΔFCF/TA 30.41 > 1.0 |
| NWC/Revenue: 221.5% < 20% (prev 77.73%; Δ 143.8% < -1%) |
| CFO/TA -0.08 > 3% & CFO -15.3m > Net Income -36.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 13.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (12.5m) vs 12m ago -8.42% < -2% |
| Gross Margin: 39.22% > 18% (prev 0.30%; Δ 3893 % > 0.5%) |
| Asset Turnover: 55.65% > 50% (prev 90.48%; Δ -34.83% > 0%) |
| Interest Coverage Ratio: -2.82 > 6 (EBITDA TTM -21.0m / Interest Expense TTM 9.41m) |
Altman Z'' -15.00
| A: 0.86 (Total Current Assets 173.0m - Total Current Liabilities 13.3m) / Total Assets 186.7m |
| B: -1.85 (Retained Earnings -346.0m / Total Assets 186.7m) |
| C: -0.20 (EBIT TTM -26.5m / Avg Total Assets 129.6m) |
| D: -20.45 (Book Value of Equity -346.5m / Total Liabilities 16.9m) |
| Altman-Z'' Score: -23.28 = D |
Beneish M -3.92
| DSRI: 0.52 (Receivables 7.01m/12.3m, Revenue 72.1m/65.5m) |
| GMI: 0.76 (GM 39.22% / 29.66%) |
| AQI: 0.60 (AQ_t 0.05 / AQ_t-1 0.08) |
| SGI: 1.10 (Revenue 72.1m / 65.5m) |
| TATA: -0.11 (NI -36.0m - CFO -15.3m) / TA 186.7m) |
| Beneish M-Score: -3.92 (Cap -4..+1) = AAA |
What is the price of AMBQ shares?
As of February 26, 2026, the stock is trading at USD 32.61 with a total of 408,356 shares traded.
Over the past week, the price has changed by +9.98%, over one month by +2.81%, over three months by +39.12% and over the past year by +35.87%.
Over the past week, the price has changed by +9.98%, over one month by +2.81%, over three months by +39.12% and over the past year by +35.87%.
Is AMBQ a buy, sell or hold?
Ambiq Micro has no consensus analysts rating.
What are the forecasts/targets for the AMBQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40 | 22.7% |
| Analysts Target Price | - | - |
AMBQ Fundamental Data Overview February 22, 2026
P/S = 7.2717
Revenue TTM = 72.1m USD
EBIT TTM = -26.5m USD
EBITDA TTM = -21.0m USD
Long Term Debt = 771.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 402.0k USD (from shortTermDebt, last quarter)
Debt = 771.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -145.7m USD (from netDebt column, last quarter)
Enterprise Value = 378.6m USD (524.4m + Debt 771.0k - CCE 146.5m)
Interest Coverage Ratio = -2.82 (Ebit TTM -26.5m / Interest Expense TTM 9.41m)
EV/FCF = -18.48x (Enterprise Value 378.6m / FCF TTM -20.5m)
FCF Yield = -5.41% (FCF TTM -20.5m / Enterprise Value 378.6m)
FCF Margin = -28.42% (FCF TTM -20.5m / Revenue TTM 72.1m)
Net Margin = -49.89% (Net Income TTM -36.0m / Revenue TTM 72.1m)
Gross Margin = 39.22% ((Revenue TTM 72.1m - Cost of Revenue TTM 43.8m) / Revenue TTM)
Gross Margin QoQ = 42.26% (prev 40.12%)
Tobins Q-Ratio = 2.03 (Enterprise Value 378.6m / Total Assets 186.7m)
Interest Expense / Debt = 1221 % (Interest Expense 9.41m / Debt 771.0k)
Taxrate = 21.0% (US default 21%)
NOPAT = -21.0m (EBIT -26.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 13.04 (Total Current Assets 173.0m / Total Current Liabilities 13.3m)
Debt / Equity = 0.00 (Debt 771.0k / totalStockholderEquity, last quarter 169.8m)
Debt / EBITDA = 6.95 (negative EBITDA) (Net Debt -145.7m / EBITDA -21.0m)
Debt / FCF = 7.11 (negative FCF - burning cash) (Net Debt -145.7m / FCF TTM -20.5m)
Total Stockholder Equity = 101.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -27.76% (Net Income -36.0m / Total Assets 186.7m)
RoE = -35.55% (Net Income TTM -36.0m / Total Stockholder Equity 101.2m)
RoCE = -26.02% (EBIT -26.5m / Capital Employed (Equity 101.2m + L.T.Debt 771.0k))
RoIC = 11.49% (negative operating profit) (NOPAT -21.0m / Invested Capital -182.4m)
WACC = 9.18% (E(524.4m)/V(525.1m) * Re(9.19%) + (debt cost/tax rate unavailable))
Discount Rate = 9.19% (= CAPM, Blume Beta Adj.)
[DCF] Fair Price = unknown (Cash Flow -20.5m)
EPS Correlation: 59.05 | EPS CAGR: 411.7% | SUE: N/A | # QB: 0
Revenue Correlation: 2.81 | Revenue CAGR: 12.57% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.37 | Chg7d=+0.015 | Chg30d=+0.019 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=-1.35 | Chg7d=+0.018 | Chg30d=+0.028 | Revisions Net=+3 | Growth EPS=+7.0% | Growth Revenue=+21.6%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
Revenue TTM = 72.1m USD
EBIT TTM = -26.5m USD
EBITDA TTM = -21.0m USD
Long Term Debt = 771.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 402.0k USD (from shortTermDebt, last quarter)
Debt = 771.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -145.7m USD (from netDebt column, last quarter)
Enterprise Value = 378.6m USD (524.4m + Debt 771.0k - CCE 146.5m)
Interest Coverage Ratio = -2.82 (Ebit TTM -26.5m / Interest Expense TTM 9.41m)
EV/FCF = -18.48x (Enterprise Value 378.6m / FCF TTM -20.5m)
FCF Yield = -5.41% (FCF TTM -20.5m / Enterprise Value 378.6m)
FCF Margin = -28.42% (FCF TTM -20.5m / Revenue TTM 72.1m)
Net Margin = -49.89% (Net Income TTM -36.0m / Revenue TTM 72.1m)
Gross Margin = 39.22% ((Revenue TTM 72.1m - Cost of Revenue TTM 43.8m) / Revenue TTM)
Gross Margin QoQ = 42.26% (prev 40.12%)
Tobins Q-Ratio = 2.03 (Enterprise Value 378.6m / Total Assets 186.7m)
Interest Expense / Debt = 1221 % (Interest Expense 9.41m / Debt 771.0k)
Taxrate = 21.0% (US default 21%)
NOPAT = -21.0m (EBIT -26.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 13.04 (Total Current Assets 173.0m / Total Current Liabilities 13.3m)
Debt / Equity = 0.00 (Debt 771.0k / totalStockholderEquity, last quarter 169.8m)
Debt / EBITDA = 6.95 (negative EBITDA) (Net Debt -145.7m / EBITDA -21.0m)
Debt / FCF = 7.11 (negative FCF - burning cash) (Net Debt -145.7m / FCF TTM -20.5m)
Total Stockholder Equity = 101.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -27.76% (Net Income -36.0m / Total Assets 186.7m)
RoE = -35.55% (Net Income TTM -36.0m / Total Stockholder Equity 101.2m)
RoCE = -26.02% (EBIT -26.5m / Capital Employed (Equity 101.2m + L.T.Debt 771.0k))
RoIC = 11.49% (negative operating profit) (NOPAT -21.0m / Invested Capital -182.4m)
WACC = 9.18% (E(524.4m)/V(525.1m) * Re(9.19%) + (debt cost/tax rate unavailable))
Discount Rate = 9.19% (= CAPM, Blume Beta Adj.)
[DCF] Fair Price = unknown (Cash Flow -20.5m)
EPS Correlation: 59.05 | EPS CAGR: 411.7% | SUE: N/A | # QB: 0
Revenue Correlation: 2.81 | Revenue CAGR: 12.57% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.37 | Chg7d=+0.015 | Chg30d=+0.019 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=-1.35 | Chg7d=+0.018 | Chg30d=+0.028 | Revisions Net=+3 | Growth EPS=+7.0% | Growth Revenue=+21.6%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)